Dwf5 mutants
OwnerSunghwa Choe, Kenneth A. Feldmanninventors
Life of this patent
Estimating the term…
Abstract
Dwarf5 (dwf5) mutants and methods of using the same are disclosed. The dwf5 polynucleotides can be used in the production of transgenic plants which display at least one dwf5 phenotype, so that the resulting plants have altered structure or morphology. Also described is the DWF5 genomic sequence.
Claims39
An isolated polynucleotide selected from the group consisting of (a) a dwf5-1 polynucleotide comprising the dwf5-1 nucleotide sequence depicted in FIG. 7;
- (b) a dwf5-2 polynucleotide comprising the dwf5-2 nucleotide sequence depicted in FIG. 7;
- (c) a dwf5-3 polynucleotide comprising the dwf5-3 nucleotide sequence depicted in FIG. 7;
- (d) a dwf5-4 polynucleotide comprising the dwf5-4 nucleotide sequence depicted in FIG. 7;
- (e) a dwf5-5 polynucleotide comprising the dwf5-5 nucleotide sequence depicted in FIG. 7;
- (f) a dwf5-6 polynucleotide comprising the dwf5-6 nucleotide sequence depicted in FIG. 7;
- (g) a DWF5 polynucleotide comprising the genomic DWF5 sequence depicted in FIG. 7;
- (h) a polynucleotide comprising a nucleotide sequence having at least about 50% sequence identity to the nucleotide sequence of (a), (b), (c), (d), (e), (f) or (g);
- (i) a fragment of (a), (b), (c), (d), (e), (f), (g) or (h) comprising at least about 15 contiguous nucleotides therefrom;
- and (j) complements or reverse complements of (a), (b), (c), (d), (e), (f), (g), (h) or (i).
An isolated polynucleotide selected from the group consisting of (a) a polynucleotide comprising a nucleotide sequence having at least about 50% sequence identity to the genomic DWF5 sequence depicted in FIG. 7;
- (b) a fragment of (a) comprising at least about 15 contiguous nucleotides therefrom;
- and (c) complements or reverse complements of (a) or (b).
An isolated polynucleotide selected from the group consisting of (a) a polynucleotide comprising the nucleotide sequence depicted at nucleotide positions 1-633 of FIG. 7;
- (b) a polynucleotide comprising the nucleotide sequence depicted at nucleotide positions 634-670 of FIG. 7;
- (c) a polynucleotide comprising the nucleotide sequence depicted at nucleotide positions 4045-4243 of FIG. 7;
- (d) a polynucleotide comprising an intron sequence as depicted in FIG. 7;
- (e) a polynucleotide comprising a nucleotide sequence having at least about 50% sequence identity to the nucleotide sequence of (a), (b), (c) or (d);
- (f) a fragment of (a), (b), (c), (d) or (e) comprising at least about 15 contiguous nucleotides therefrom;
- and (g) complements or reverse complements of (a), (b), (c), (d), (e) or (f).
A chimeric polypeptide comprising a first amino acid sequence of a DWF5 polypeptide and a second amino acid sequence of a heterologous polypeptide.
Dependencies are inferred from the claim text.